Skip to main content

Table 2 Baseline demographic and clinical characteristics of the 36 randomized study patients (intention-to-treat population) by treatment assignment

From: Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial

 

Overall

N = 36

HTB Group

(N = 17)

Placebo Group

(N = 19)

P Valuea

Gender (female/male), n

28/8

14/3

14/5

0.70

Age (years)

47 (11.9)

44 (13.0)

49 (10.6)

0.22

BMI (kg/m2)

24 (5.2)

24 (3.9)

25 (6.3)

0.72

Duration of depression (months)

93 (85.7)

98 (92.5)

89 (82.7)

0.79

Use of psychopharmaca (%)

64

65

63

1

HAM-Dtotal score

22.36 (3.7)

23.06 (3.9)

21.74 (3.4)

0.29

HAM-Dinsomnia

3.36 (2.0)

3.35 (1.8)

3.37 (2.3)

0.98

HAM-Dmood

10.47 (2.1)

10.82 (1.8)

10.16 (2.3)

0.35

HAM-Dsomatic

3.92 (1.2)

4.00 (1.3)

3.84 (1.2)

0.71

Heart rate (21:00-04:00)b

72.77 (10.8)

73.20 (9.4)

72.39 (12.2)

0.84

HRV LF (21:00-04:00)b

490.30 (329.8)

485.70 (353.6)

494.33 (319.3)

0.94

HRV HF (21:00-04:00)b

161.94 (133.8)

156.47 (154.6)

166.72 (117.6)

0.84

HRV SDNN (21:00-04:00)b

55.14 (16.5)

55.33 (15.9)

54.97 (17.6)

0.95

  1. Where not otherwise indicated, data are shown as mean and standard deviation (SD)
  2. Abbreviations: HTB hyperthermic baths, BMI body mass index (calculated as weight in kilograms divided by height in meters squared)
  3. aCalculated as comparisons of HTB and placebo, using 2-tailed t tests (continuous variables) or χ2 tests (discrete variables)
  4. bNight-time intervals